Developmental immunotoxicity testing of 4-methyl anisole
Publication date
2015-07
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
The developmental immunotoxicity of 4-methyl anisole (4MA) was investigated in the rat. Four study designs were used, with either premating or post-weaning onset of exposure, continued to postnatal day 50, and with or without additional oral gavage of pups from postnatal day 10 onward. Reduced litter size (benchmark dose lower confidence limit (BMDL) 80 mg/kg bw/day) was the most sensitive developmental parameter, with pup relative organ weight effects observed at similar BMDLs, in the absence of maternal toxicity. Eosinophil numbers were reduced at lower doses (BMDL 16 mg/kg bw/day). KLH challenge resulted in increased IL-13 and TNF-alpha responses, and variably reduced IgG production (BMDL 27 mg/kg bw/day). T-4 levels were reduced by 11% at maximum with a BMDL of 73 mg/kg bw/day. Differences between exposure cohorts were limited and were considered to be without biological significance. This study shows that 4MA induces developmental immunotoxicity at doses below those inducing developmental and general toxicity. These observations being independent of the study designs applied suggest that the post-weaning period, included in all designs, is the most relevant sensitive period for inducing 4MA mediated developmental immunotoxicity. Moreover, this study stresses the importance of including developmental immunotoxicity testing by default in regulatory toxicology. (C) 2015 Elsevier Inc. All rights reserved.
Keywords
4-Methyl anisole, Developmental toxicity, Developmental immunotoxicity, Prenatal exposure, Benchmark dose, MALE RATS, RELATIVE SENSITIVITY, PERINATAL EXPOSURE, IMMUNE PARAMETERS, JUVENILE EXPOSURE, ADULT, DICHLORIDE, TOXICITY, ETHANOL, SYSTEM, Taverne
Citation
Tonk, E C M, Verhoef, A, Gremmer, E R, van Loveren, H & Piersma, A H 2015, 'Developmental immunotoxicity testing of 4-methyl anisole', Regulatory Toxicology and Pharmacology, vol. 72, no. 2, pp. 379-385. https://doi.org/10.1016/j.yrtph.2015.04.003